Sage Therapeutics' financials indicate a need for additional funding in 2025, risking dilution and further financial ...

By one estimate, 68% of Americans consume less than the recommended dietary amount of magnesium. Magnesium is essential for ...

Experts say there’s been a rise in young people taking 'Xanax' recreationally in Australia. The drug is usually prescribed to ...

These non-alcoholic beverages include ingredients like nootropics and adaptogens which may boost your mood — without the ...

In states where both medical and recreational marijuana are legal, fewer patients are filling prescriptions for medications ...

Feeling down? What is on your plate might be playing a bigger role in your mood than you think. Depression is a growing ...

Depression continues to grapple a large proportion of the population. Given the side effects associated with the long-term use of conventional antidepressants, there is a need for novel rapid acting ...

Melatonin, available in various forms like gummies, pills, and liquid, has become a go-to for many with insomnia ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions, current medications have several limitations, ...

When 35-year-old Shruti Nagpal from Noida faced sleep issues, she tried ‘melatonin gummies’ on an experimental basis. “They ...

Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that Chief Executive Officer Barry Greene will discuss the Company’s strategic focus areas for 2025 at the 43rd Annual J.P. Morgan Healthcare ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions ...